1 Jemal A,Center MM,DeSant C,et al.Global patterns of cancer incidence and mortality rates and trends [J].Cancer Epidemiol Biomarkers Prev,2010,19(8):1893-1907. 2 Chen WQ,Zhang SW,Zou XN.Estimation and projection of lung cancer incidence and mortality in china [J].Chinese Journal of Lung Cancer,2010,13(5):488-493. 3 董颖,赵长宏.基质金属蛋白酶与肿瘤侵袭转移的研究进展[J].实用肿瘤学杂志,2007,21(04):384-386. 4 Nyalendo C,Sartelet H,Gingras D,et al.Inhibition of membrane type 1 matrix metalloproteinase tyrosine phosphorylation blocks tumor progression in mice [J].Anticancer Res,2010,30(6):1887-1895. 5 张平峰,蔡军,吴安涛.MMP-7在肿瘤中的研究进展[J].实用临床医学,2014,15(2):131-133. 6 章冬银,孙冰丽,顾月清.基质金属蛋白酶7在肿瘤中的作用及其机制研究进展[J].药物生物技术,2011,18(5):457-460. 7 Chelladurai P,Seeger W,Pullamsetti SS.Matrix metalloproteinases and their inhibitors in pulmonary hypertension [J].Eur Respir J,2012,40(3):766-782. 8 Fujishima S,Shiomi T,Yamashita S,et al.Production and activation of matrix metalloproteinase 7(matrilysin-1)in the lungs of patients with idiopathic pulmonary fibrosis [J].Arch Pathol Lab Med,2010,8(134):1136-1142. 9 李峰,孙晓菊,谢洪,等.牙周炎患者血清MMP-9、MMP-7以及MCP-1水平与颈动脉斑块不稳定性的相关性研究[J].上海口腔医学,2015,24(5):589-593. 10 Tao YL,Qiu XX,Xu CB,et al.Expression and correlation of matrix metalloproteinase-7 and interleukin-15 in human osteoarthritis [J].International Journal of Experimental Pathology,2015,8(8):9112-9118. 11 Scherf DB,Dally H,Muller P,et al.Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis [J].Eur Respir,2010,35(2):381-390. 12 Liu D,Guo H,Li Y,et al.Association between polymorphisms in the promoter regions of matrix metalloproteinases(MMPs)and risk of cancer metastasis:a meta-analysis [J].PLoS One,2012,7(2):e31251. 13 Pan FY,Zhang SZ,Xu N,et al.Beta-catenin signaling involves HGF-enhanced HepG2 scattering through activating MMP-7 transcription [J].Histochem Cell Biol,2010,134(3):285-295. 14 Li NG,Tang YP,Duan JA,et al.Matrix metalloproteinase inhibitors:a patent review(2011-2013)[J].Expert Opin Ther,2014,24(9):1039-1052. 15 刘辉,吕丽琼,莫小勤,等.MMP-2、MMP-7、MMP-9、TIMP-1及TIMP-2在乳腺癌组织中的表达及意义[J].现代生物医学进展,2015,16(2):3046-3048. 16 卢壁辉,黄壮生.MMP-7、VEGF-C和VEGFR-3在结肠癌组织中的表达及相关性[J].广东医学,2015,6(2):878-880. 17 比丽克孜·艾克木,封敏,李秀梅,等.MTA1、MMP-2、MMP-7在宫颈癌的表达及其意义[J].中国现代医学,2013,23(29):51-54. 18 Zhu R,Tian Y.Astrocyte elevated gene-1 increases invasiveness of NSCLC through up-regulating MMP7 [J].Cellular Physiology and Biochemistry,2015,37(3):1187-1195. 19 Kim EJ,Lee SY,Woo MK,et al.Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation [J].International Journal of Oncology,2012,40(2):402-408. 20 Sun X,Xiao T,Yang L,et al.The expression level and clinical significance of MMP-7 protein in peripheral blood in the patients with lung cancer [J].Chinese Journal of Lung Cancer,2012,15(12):725-729. 21 钱凌,揭志军,谢娟,等.基质金属蛋白酶和金属蛋白酶组织抑制剂对良恶性胸腔积液的鉴别诊断价值[J].中国临床医学,2015,22(1):54-56. 22 Hsu TI,Lin SC,Lu PS,et al.MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy [J].Oncogene,2015,34(7):826-837. 23 Stenvold H,Donnem T,Andersen S,et al.Overexpression of matrix metalloproteinase-7 and-9 in NSCLC tumor and stromal cells:correlation with a favorable clinical outcome [J].Lung Cancer,2012,75(2):235-241. 24 Yamamoto T,Oshima T,Yoshihara K,et al.Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer [J].Experimental and Therapeutic Medicine,2012,3(5):797-802. 25 Liang YG,Guo SX,Zhou QH.Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer [J].Tumour Biology,2013,35(4):3717-3724. |